Willi McFarland, MD, PhD, MPH&TM Director, Center for Public Health Research January 16, 2018 Health Commission Community Meeting Population Health Division Center for Public Health Research Protecting and Promoting Health and Equity San Francisco Department of Public Health
15
Embed
Center for Public Health Research · 1/16/2018 · •Substance use research: Epidemiology, prevention, reduction, and mitigation of harm • HIV epidemiology research: Epidemiology
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Willi McFarland, MD, PhD, MPH&TMDirector, Center for Public Health Research
January 16, 2018Health Commission Community Meeting
Population Health Division
Center for Public Health Research
Protecting and Promoting Health and Equity
San Francisco Department of Public Health
City and County of San FranciscoLondon Bree
Mayor
You are here
We are here
Where are we?
Willi
TBD
Erin
Sean
Dillon
Caitlin
Victory
Jess
Sofia
Corey
Sophia
Ariana
Yea-Hung TBD
John G
Jan Bing
Desmond
Travis
Andrew
Rachel
Milo
Chris R
Claudine
Maximo
Phillip
Emily B Tim
Lamont
Emily Hall Natalie
Rita
Deeqa
Sophie
Melody
Amy
John W Jaclyn
Arsheen Marcial Sarah John F
Duane
Rob L
Kimberly
Who are we? Center for Public Health Research
Substance Use Research Unit (SURU)
HIV Epidemiology Research Unit
Transgender Health Research
Unit
• Research
• Ideally: Capacity in all areas of health of San Franciscans
• Reality: Leverage our strengths in a few areas in which we excel
• Get grants: 60 as primary or collaborator ~$4,000,000 per year
• CPHR is >95% extramurally funded(indirects go to City and County)
• Substance use research: Epidemiology, prevention, reduction, and mitigation of harm
• HIV epidemiology research: Epidemiology and surveillance of factors leading to HIV infection and related diseases
• Transgender health research: Understanding structural, behavioral, and biological factors underlying health disparities
• Capacity-building, technical assistance, teaching research methods: Building the pipeline of future public health researchers, helping other health departments in areas of San Francisco’s strengths
5
What do we? Areas in which we excel
Substance Use Research Unit (SURU): Epidemiology, prevention, reduction, and mitigation of harm
Opioid health indicators, San Francisco
Substance Use Research Unit (SURU): Epidemiology, prevention, reduction, and mitigation of harm
Naloxone enrollments, refills, and reversal reports to the Drug Overdose Prevention and Education Project, San Francisco
30
SURU: Training rural county providers on opioid prescribing, naloxone co-prescribing, and buprenorphine use
SiskiyouHumboldtShastaLakeButtePlumasSanta Cruz
More to come next year!
Next round: Los AngelesSan Diego
40%
23%
12%
0.09% 0.04%0
5
10
15
20
25
30
35
40
45
Transwomen MSM IDU Heterosexualwomen
Heterosexualmen
HIV Epidemiology Research UnitHIV prevalence: Trans women, MSM, IDU, HRH
HIV Epidemiology Research UnitHIV prevalence: Trans women
0
5
10
15
20
25
30
35
40
45
2010 2013 2016
Trans women
Some HIV prevention successes;Remaining HIV care challenges